Michael Quartuccio is an Endocrinology/Metabolic physician affiliated with Unity Health System. OpenAlex indexes 22 publications with 239 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
39 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
39 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
70%Insulin Analog21.9%Lantus Solostar21%Insulin Lispro Kwikpen U-10015%Humalog Kwikpen U-1008%Insulin Lispro7%Toujeo Max Solostar7%Basaglar Kwikpen U-1006%Toujeo Solostar5%Novolog Flexpen5%Humalog4%Soliqua 100-334%Novolog3%Insulin Glargine Solostar2%Xultophy 100-3.62%Tresiba Flextouch U-1002%Tresiba Flextouch U-2002%Lantus2%Levemir Flexpen1%Humalog Kwikpen U-2001%Fiasp Flextouch1%Humalog Junior Kwikpen1%Insulin Glargine-Yfgn1%Part D<11 patientsGLP-1 receptor agonist21.5%Ozempic45%Trulicity42%Rybelsus6%Mounjaro5%Victoza 3-Pak2%Part D<11 patients+ 8 more classes in this area
Hormonal (systemic)
16.5%l-Thyroxine11.7%Levothyroxine Sodium79%Synthroid14%Euthyrox5%Tirosint3%Part D<11 patientsThyroid Hormone Synthesis Inhibitor3%Methimazole100%Part D≥54 patients+ 5 more classes in this area
Cardiovascular
8.7%Statin5.3%Atorvastatin Calcium49%Rosuvastatin Calcium42%Simvastatin9%Part D<11 patientsACE inhibitor1.8%Lisinopril74%Ramipril26%Part D≥26 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- SUN-781 Isolated Non-PTH-Mediated Hypercalcemia: A Rare Presentation of Sarcoidosis
Journal of the Endocrine Society
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Peter Kouides, MD
Unity Health System
Laurie Proia, MD
Unity Health System
Devesh Rai, MD
Unity Health System
Peter Capucilli, MD
Unity Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”